A world where every cancer patient receives the right therapy

Our mission is to improve the use of advanced cancer drugs by providing healthcare systems with solutions for highly accurate mutation detection.

Oncodia develops regulatory approved software for sequencing analyses of tumors to guide the use of targeted therapies and checkpoint inhibitors.

We empower healthcare providers with the quality and regulatory approval previously only available through service providers, so sensitive data can stay where they belong and turnaround times remain short.